Clyde Sydney Martin, MD in Athens, TN - Urology

Clyde Sydney Martin, MD is a Urology physician based in Athens, Tennessee. Clyde Sydney Martin is licensed to practice in Tennessee (license number MD0000012786) and his current practice location is 119 Epperson St, Athens, Tennessee. He can be reached at his office (for appointments etc.) via phone at (423) 745-7500.

NPI number for Clyde Sydney Martin is 1346324977 and his current mailing address is 119 Epperson St, Po Box 726, Athens, Tennessee. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1346324977.

Contact Information

	Clyde Sydney Martin, MD
	119 Epperson St, Athens, TN 37303-3478
	(423) 745-7500
	(423) 745-7501

Physician's Profile

Full Name	Clyde Sydney Martin
Gender	Male
Speciality	Urology
Location	119 Epperson St, Athens, Tennessee
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1346324977
Provider Enumeration Date: 10/24/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Clyde Sydney Martin such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1346324977	NPI	-	NPPES
37363	Other	TN	BLUE CROSS BLUE SHIELD

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208800000X	Urology	MD0000012786 (Tennessee)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Clyde Sydney Martin is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Clyde Sydney Martin, MD 119 Epperson St, Po Box 726, Athens, TN 37303-3478 Ph: (423) 745-7500	Clyde Sydney Martin, MD 119 Epperson St, Athens, TN 37303-3478 Ph: (423) 745-7500

News Archive

Lower dose of clot-busting agent may reduce the need for mechanical clot removal in stroke patients

New research confirms that the lower 0.25 mg/kg dose of the clot-busting agent tenecteplase is appropriate for eligible stroke patients and can reduce the need for mechanical clot removal, according to late breaking science presented today at the American Stroke Association's International Stroke Conference 2020.

Milk helps children to stay hydrated during exercise than water

Active children need to be watered with milk. It's a more effective way of countering dehydration than a sports drink or water itself, say researchers at McMaster University.

With repeal still on the table, health debate detente expected to be temporary

Although GOP interest in turning back the health law remains strong, lawmakers' face the challenge of tempering some of their rhetoric in the wake of the Tucson shootings. Meanwhile, people on both sides of the aisle say this "timeout" is likely to be only temporary.

FDA investigates school lunch illness in Massachusetts

The U.S. Food and Drug Administration (FDA), the Massachusetts Department of Public Health and the U.S. Centers for Disease Control and Prevention are actively investigating what may have caused four outbreaks of illnesses in children related to meals served at several schools in Massachusetts.

Adults with herpes zoster may face higher risk of multiple sclerosis

Taiwanese investigators have found that there can be a significantly higher risk of multiple sclerosis (MS) occurring in the year following a shingles, or herpes zoster, attack.

Clyde Sydney Martin, MD - Urology in Athens, TN